Glycopeptide and lipopeptide antibiotics with potent activity against multi-drug resistant bacteria responsible for uti, csssi and cap/np infections
- In: AUSTRALIAN SHOWCASE: DRUG DISCOVERY AND DEVELOPMENT IN AUSTRALIA on Monday, 14 April 2014, 16:00-17:30
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: COOPER (Australia)
- Co-author(s): Blaskovich, Mark (University of Queensland, Brisbane, Australia)
Butler, Mark (University of Queensland, Brisbane, Australia)
Becker, Bernd (University of Queensland, Brisbane, Australia)
Cheng, Mu (University of Queensland, Brisbane, Australia)
Da Silva, Alberto (University of Queensland, Brisbane, Australia)
Elliot, Alysha (University of Queensland, Brisbane, Australia)
Gallardo-Godoy, Alejandra (University of Queensland, Brisbane, Australia)
Hansford, Karl (University of Queensland, Brisbane, Australia)
Lindahl, Fredrik (University of Queensland, Brisbane, Australia)
Paterson, David (University of Queensland, Brisbane, Australia)
Ziora, Zyta (University of Queensland, Brisbane, Australia) - Abstract:
Background: The paucity of drugs for systemic treatment of multi-drug resistant bacterial infections is one of the most pressing health issues currently facing humankind. New approaches to antibiotic discovery are needed.
Aims & Methods: We designed lipopeptide and glycopeptide derivatives selective for bacterial membranes over mammalian.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023